• Users Online: 464
  • Print this page
  • Email this page


 
 
Table of Contents
ERRATUM
Year : 2019  |  Volume : 8  |  Issue : 2  |  Page : 67

Erratum: Could Biglycan be a Biomarker of Coronary Artery Disease? A Pilot Human Study


Date of Web Publication03-Oct-2019

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2251-9572.268474

Get Permissions


How to cite this article:
. Erratum: Could Biglycan be a Biomarker of Coronary Artery Disease? A Pilot Human Study. Res Cardiovasc Med 2019;8:67

How to cite this URL:
. Erratum: Could Biglycan be a Biomarker of Coronary Artery Disease? A Pilot Human Study. Res Cardiovasc Med [serial online] 2019 [cited 2019 Oct 18];8:67. Available from: http://www.rcvmonline.com/text.asp?2019/8/2/67/268474



In the article titled “Could Biglycan be a Biomarker of Coronary Artery Disease? A Pilot Human Study” , published on pages 144-147, Issue 3, Volume 7 of Research in Cardiovascular Medicine [1], the affiliation of Sepideh Elyasi is written incorrectly as “Department of Research and Education, Razavi Hospital, Mashhad, Iran” instead of “Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran”.



 
  References Top

1.
Rezapour A, Moradian M, Nazemi S, Moallem SA, Issazadeh S, Elyasi S, et al. Could Biglycan be a biomarker of coronary artery disease? A pilot human study. Res Cardiovasc Med 2018;7:144-7.  Back to cited text no. 1
  [Full text]  




 

Top
 
  Search
 
    Similar in PUBMED
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed33    
    Printed0    
    Emailed0    
    PDF Downloaded5    
    Comments [Add]    

Recommend this journal